Two‐year outcomes after percutaneous coronary intervention with drug‐eluting stents or bare‐metal stents in elderly patients with coronary artery disease - Aix-Marseille Université Access content directly
Journal Articles Catheterization and Cardiovascular Interventions Year : 2021

Two‐year outcomes after percutaneous coronary intervention with drug‐eluting stents or bare‐metal stents in elderly patients with coronary artery disease

Didier Carrié
  • Function : Author
  • PersonId : 942695
Gérard Helft
  • Function : Author
  • PersonId : 993920
Olivier Varenne

Abstract

Objectives Report the results at 2 years of the patients included in the SENIOR trial. Background Patients above 75 years of age represent a fast-growing population in the cathlab. In the SENIOR trial, patients treated by percutaneous coronary intervention (PCI) with drug eluting stent (DES) and a short duration of P2Y12 inhibitor (1 and 6 months for stable and unstable coronary syndromes, respectively) compared with bare metal stents (BMS) was associated with a 29% reduction in the rate of all-cause mortality, myocardial infarction (MI), stroke, and ischaemia-driven target lesion revascularization (ID-TLR) at 1 year. The results at 2 years are reported here. Methods and Results We randomly assigned 1,200 patients (596[50%] to the DES group and 604[50%] to the BMS group). At 2 years, the composite endpoint of all-cause mortality, MI, stroke and ID-TLR had occurred in 116 (20%) patients in the DES group and 131 (22%) patients in the BMS group (RR 0.90 [95%CI 0.72-1.13],p= .37). IDTLR occurred in 14 (2%) patients in the DES group and 41 (7%) patients in the BMS group (RR 0.35 [95%CI 0.16-0.60],p= .0002). Major bleedings (BARC 3-5) occurred in 27(5%) patients in both groups (RR 1.00, [95%CI 0.58-1.75],p= .99). Stent thrombosis rates were low and similar between DES and BMS (0.8 vs 1.3%, (RR 0.52 [95%CI 0.01-1.95],p= .27). Conclusion Among elderly PCI patients, a strategy combining a DES together with a short duration of DAPT is associated with a reduction in revascularization up to 2 years compared with BMS with very few late events and without any increased in bleeding complications or stent thrombosis.
Fichier principal
Vignette du fichier
SENIOR 2 Years Final revised05062020.pdf (238.9 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03164263 , version 1 (19-09-2023)

Identifiers

Cite

Alexandre Lafont, Peter Sinnaeve, Thomas Cuisset, Stéphane Cook, Giorgios Sideris, et al.. Two‐year outcomes after percutaneous coronary intervention with drug‐eluting stents or bare‐metal stents in elderly patients with coronary artery disease. Catheterization and Cardiovascular Interventions, 2021, 97 (5), pp.E607-E613. ⟨10.1002/ccd.29159⟩. ⟨hal-03164263⟩
127 View
10 Download

Altmetric

Share

Gmail Facebook X LinkedIn More